38. Skowronski,J. and Singer,M.F. (1985) Expression of a cytoplasmic LINE-1 transcript is regulated in a human teratocarcinoma cell line. Proc. Natl Acad. Sci. USA, 82, 6050–6054. 39. Peterson,M.L., Bryman,M.B., Peiter,M. and Cowan,C. (1994) Exon size affects competition between splicing and cleavage- polyadenylation in the immunoglobulin mu gene. Mol. Cell. Biol., 14, 77–86. 40. Batt,D.B., Rapp,L.M. and Carmichael,G.G. (1994) Splice site selection in polyomavirus late pre-mRNA processing. J. Virol., 68, 1797–1804. 41. Luo,Y. and Carmichael,G.G. (1991) Splice site choice in a complex transcription unit containing multiple inefficient polyadenylation signals. Mol. Cell. Biol., 11, 5291–5300. 42. Roca,X., Sachidanandam,R. and Krainer,A.R. (2005) Determinants of the inherent strength of human 50 splice sites. RNA, 11, 683–698. 43. Chen,C.D. and Helfman,D.M. (1999) Donor site competition is involved in the regulation of alternative splicing of the rat beta-tropomyosin pre- mRNA. RNA, 5, 290–301. 44. Batt,D.B., Luo,Y. and Carmichael,G.G. (1994) Polyadenylation and transcription termination in gene constructs containing multiple tandem polyadenylation signals. Nucleic Acids Res., 22, 2811–2816. 45. Kulpa,D.A. and Moran,J.V. (2005) Ribonucleoprotein particle formation is necessary but not sufficient for LINE-1 retrotransposition. Hum. Mol. Genet.,, 14, 3237–3248. 46. Kazazian,H.H.,Jr (2004) Mobile elements: drivers of genome evolution. Science, 303, 1626–1632. 47. Moran,J.V., Gilbert,N., Boeke,J., Kazazian,H., Ostertag,E., Loon,S. and Wei,W. (2000) Human L1s retrotransposition: cis-preference vs trans- complementation. Am. J. Hum. Genet., 67, 199. 48. Lewis,B.P., Green,R.E. and Brenner,S.E. (2003) Evidence for the widespread coupling of alternative splicing and nonsense-mediated Nucleic Acids Research, 2006, Vol. 34, No. 5 1521 mRNA decay in humans. Proc. Natl Acad. Sci. USA, 100, 189–192. 49. Nagy,E. and Maquat,L.E. (1998) A rule for termination-codon position within intron-containing genes: when nonsense affects RNA abundance. Trends Biochem. Sci., 23, 198–199. 50. Wei,W., Gilbert,N., Ooi,S.L., Lawler,J.F., Ostertag,E.M., Kazazian,H.H., Boeke,J.D. and Moran,J.V. (2001) Human L1 retrotransposition: cis preference versus trans complementation. Mol. Cell. Biol., 21, 1429–1439. 51. Dewannieux,M., Esnault,C. and Heidmann,T. (2003) LINE-mediated retrotransposition of marked Alu sequences. Nature Genet., 35, 41–48. 52. Buzdin,A., Ustyugova,S., Gogvadze,E., Vinogradova,T., Lebedev,Y. and Sverdlov,E. (2002) A new family of chimeric retrotranscripts formed by a full copy of U6 small nuclear RNA fused to the 30 terminus of l1. Genomics, 80, 402–406. 53. Ostertag,E.M. and Kazazian,H.H. (2001) Twin priming: a proposed mechanism for the creation of inversions in L1 retrotransposition. Genome Res., 11, 2059–2065. 54. Sorek,R., Ast,G. and Graur,D. (2002) Alu-containing exons are alternatively spliced. Genome Res., 12, 1060–1067. 55. Dotzlaw,H., Alkhalaf,M. and Murphy,L.C. (1992) Characterization of estrogen receptor variant mRNAs from human breast cancers. Mol. Endocrinol., 6, 773–785. 56. Fairbrother,W.G., Yeo,G.W., Yeh,R., Goldstein,P., Mawson,M., Sharp,P.A. and Burge,C.B. (2004) RESCUE-ESE identifies candidate exonic splicing enhancers in vertebrate exons. Nucleic Acids Res., 32, W187–W190. 57. Han,J.S. and Boeke,J.D. (2004) A highly active synthetic mammalian retrotransposon. Nature, 429, 314–318.